Figure 1 The differentiated expression of RIPOR3 and correlation with survival outcomes. (A) Differentiated expression of RIPOR3 in normal tongue tissue (n=13) and oral squamous cell carcinoma of the mobile tongue (OTSCC) (n=127) in the The Cancer Genome Atlas cohort (P<0.0001). (B) Paired heterogeneous analysis of RIPOR3 expression in normal and tumor samples derived from the same patient (P=0.002 by the Wilcoxon rank-sum test). (C–E) Kaplan-Meier survival analysis of the relationship between RIPOR3 mRNA expression and overall survival (P=0.003), progression-free interval (P=0.017) and disease-specific survival (P=0.005) in OTSCC cases.